器官移植患者接受种植治疗时的临床思考  

Clinical considerations of organ transplant patients receiving implant therapy

作　　者：汤祎熳 邱立新[1] Tang Yiman;Qiu Lixin(Department of Fourth Clinical Division,Peking University School and Hospital of Stomatology&National Center of Stomatology&National Clinical Research Center for Oral Diseases&National Engineering Research Center of Oral Biomaterials and Digital Medical Devices,Beijing 100081,China)

机构地区：[1]北京大学口腔医学院·口腔医院第四门诊部、国家口腔医学中心、国家口腔疾病临床医学研究中心、口腔生物材料和数字化诊疗装备国家工程研究中心,100081

出　　处：《中国口腔种植学杂志》2024年第4期297-302,共6页Chinese Journal of Oral Implantology

基　　金：北大医学青年科技创新扬帆计划(BMU2024YFJHMX010)。

摘　　要：器官移植为严重器官衰竭的患者提供了有效的治疗手段。随着该类人群平均寿命的延长,器官移植患者对缺失牙的修复需求不断增长。种植牙已成为修复缺失牙的首选治疗方法。尽管种植牙在健康成年人中具有很高的成功率,但对器官移植患者来说,由于他们移植前患有的全身性疾病和终身需要接受的免疫抑制治疗,进行种植修复的风险会有所增加。本文对器官移植患者口腔种植治疗的特殊性及成功率进行了阐述,并进一步论述了对器官移植患者进行种植治疗时如何进行全面评估,以及如何制定个性化治疗方案以预防可能的风险和并发症,以期为器官移植患者实施安全有效的种植治疗提供临床参考。Organ transplantation is an effective treatment for end-stage organ disease.Based on the increase in life expectancy,the demand for restoration of missing teeth in organ transplant patients has gradually increased.Dental implants have become the preferred treatment of choice for restoring missing teeth.Although dental implants have high success rates in healthy adults,the risk of implant therapy is correspondingly increased in organ transplant patients with previous systemic diseases and immunosuppressive therapy.In this article,we describe the particularity and success of oral implant therapy in organ transplant patients,and further discuss how to conduct a comprehensive assessment when performing implant therapy in organ transplant patients.Besides,we also discuss how to develop an individualized treatment plan to prevent possible risks and complications,in order to provide clinical references for the implementation of safe and effective implant therapy for organ transplant patients.

关 键 词：器官移植 口腔种植 免疫抑制剂 种植体留存率 

分 类 号：R783.6[医药卫生—口腔医学] R617[医药卫生—临床医学]